Kv1.3 blocking alkoxypsoralens - A new class of immunosuppressants for the potential treatment of multiple sclerosis

被引：0
|
作者：
Wulff, H
Vennekamp, J
Beeton, C
Grissmer, S
Chandy, KG
机构：
[1] Univ Calif Irvine, Irvine, CA 92697 USA
[2] Univ Ulm, D-89069 Ulm, Germany
[3] Univ Kiel, Inst Pharmaceut, D-24098 Kiel, Germany
来源：
FASEB JOURNAL | 2003年 / 17卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1051 / A1051
页数：1
相关论文
共 50 条
  • [41] Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels: implication for multiple sclerosis therapy
    Beeton, C
    Pennington, MW
    Singh, S
    Nugent, D
    Crossley, G
    Khaytin, I
    Langer, J
    Calabresi, P
    Chandy, KG
    BIOPHYSICAL JOURNAL, 2005, 88 (01) : 279A - 279A
  • [42] Pharmacological blockade of KV1.3 channel as a promising treatment in autoimmune diseases
    Canas, Carlos A.
    Castano-Valencia, Santiago
    Castro-Herrera, Fernando
    JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2022, 5
  • [43] Immunosuppressive effects of new thiophene-based KV1.3 inhibitors
    Gubic, Spela
    Montalbano, Alberto
    Sala, Cesare
    Becchetti, Andrea
    Hendrickx, Louise Antonia
    Van Theemsche, Kenny M.
    Pinheiro-Junior, Ernesto Lopes
    Altadonna, Ginevra Chioccioli
    Peigneur, Steve
    Ilas, Janez
    Labro, Alain J.
    Pardo, Luis A.
    Tytgat, Jan
    Tomasic, Tihomir
    Arcangeli, Annarosa
    Masic, Lucija Peterlin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 259
  • [44] Design of New Potent and Selective Thiophene-Based KV1.3 Inhibitors and Their Potential for Anticancer Activity
    Gubic, Spela
    Hendrickx, Louise Antonia
    Shi, Xiaoyi
    Toplak, Zan
    Mozina, Stefan
    Van Theemsche, Kenny M.
    Pinheiro-Junior, Ernesto Lopes
    Peigneur, Steve
    Labro, Alain J.
    Pardo, Luis A.
    Tytgat, Jan
    Tomasic, Tihomir
    Masic, Lucija Peterlin
    CANCERS, 2022, 14 (11)
  • [45] Kv1.3 Expression on Urinary Leukocytes in Lupus Nephritis: Potential for Targeted Immunotherapy
    Stevens, Anne
    Hinkle, Andrew
    Yuasa, Megan
    Peckham, David
    Olsen, Chelsea
    Philips, Craig
    Iadonato, Shawn P.
    Probst, Peter
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 50 - 50
  • [46] Selective, Potent, Brain-Penetrant Kv1.3 Blockade Abrogates Inflammatory Processes Relevant for Multiple Sclerosis in Brain and Blood
    Pedersen, Marianne Terndrup
    Kuczek, Dorota
    Dalby, Maria
    Baltussen, Lucas
    Valadas, Jorge
    Comer, Ashley
    Vang, Dorthe
    Afrang, Negin
    De Bruyne, Lore
    Geric, Ivana
    Sans, Laura
    Roenn, Lars Christian
    Polydoro, Manuela
    Balice-Gordon, Rita
    De Strooper, Bart
    Plath, Niels
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 339 - 339
  • [47] Lymphocyte calcium influx characteristics and its modulation by Kv1.3 and IKCa1 potassium channel inhibitors in multiple sclerosis
    Folyovich, A.
    Toldi, G.
    Simon, Z.
    Zsiga, K.
    Vastagh, I.
    Kaposi, A.
    Ambrus, G.
    Tulassay, T.
    Vasarhelyi, B.
    JOURNAL OF NEUROLOGY, 2011, 258 : 92 - 93
  • [48] Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases
    Chhabra, Sandeep
    Chang, Shih Chieh
    Nguyen, Hai M.
    Huq, Redwan
    Tanner, Mark R.
    Londono, Luz M.
    Estrada, Rosendo
    Dhawan, Vikas
    Chauhan, Satendra
    Upadhyay, Sanjeev K.
    Gindin, Mariel
    Hotez, Peter J.
    Valenzuela, Jesus G.
    Mohanty, Biswaranjan
    Swarbrick, James D.
    Wulff, Heike
    Iadonato, Shawn P.
    Gutman, George A.
    Beeton, Christine
    Pennington, Michael W.
    Norton, Raymond S.
    Chandy, K. George
    FASEB JOURNAL, 2014, 28 (09): : 3952 - 3964
  • [49] The Voltage- and time-dependent blocking effect of trifluoperazine on T lymphocyte Kv1.3 channels
    Teisseyre, A
    Michalak, K
    BIOCHEMICAL PHARMACOLOGY, 2003, 65 (04) : 551 - 561
  • [50] Stroke: Kv1.3 inhibition shows therapeutic potential in animal models of ischaemic stroke
    Wood H.
    Nature Reviews Neurology, 2018, 14 (3) : 127 - 127
12345